Concepedia

M. Álvarez-Múgica

MÁ

7

Publications

443

Citations

7

H-Index

2006

Active since

Affiliations

Hospital Universitario Central de Asturias(Current)

Spanish National Cancer Research Centre

Centro de Investigación del Cáncer

Puigvert Foundation

Uppsala University

M. Álvarez-Múgica is an author at Hospital Universitario Central de Asturias specializing in pathology, medicine, and cancer research.

Top concepts

Publications per year

2006–2012

7

Publications

7

miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer

Patricia Puerta, Rodrigo García-Baquero, Angela Y. Jia et al. · American Journal Of Pathology · 2012 · 160 citations

, , +10

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

Niels Fristrup, Benedicte Parm Ulhøi, Karin Birkenkamp‐Demtröder et al. · American Journal Of Pathology · 2012 · 82 citations · Full text

, , +7

Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer

Niels Fristrup, Karin Birkenkamp‐Demtröder, Thomas Reinert et al. · American Journal Of Pathology · 2012 · 77 citations · Full text

, , +11

Urinary CYFRA 21.1 Is Not a Useful Marker for the Detection of Recurrences in the Follow-Up of Superficial Bladder Cancer

J.M. Fernández Gómez, Juan J. Rodríguez-Martínez, S. Escaf Barmadah et al. · European Urology · 2006 · 45 citations

, , +8

Myopodin Methylation is Associated With Clinical Outcome in Patients With T1G3 Bladder Cancer

M. Álvarez-Múgica, Virginia Cebrián, J.M. Fernández Gómez et al. · The Journal of Urology · 2010 · 37 citations

Rows per page

1–5 of 7